The interaction between 5-hydroxytryptamine and botulinum toxin type A.
D006916:5-Hydroxytryptophan / Q000494:pharmacology; D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D000992:Antitoxins; D001906:Botulism / Q000401:mortality; D002713:Chlorine; D003014:Clostridium botulinum; D003964:Diaphragm; D005260:Female; D006897:Hydroxyindoleacetic Acid / Q000494:pharmacology; D066298:In Vitro Techniques; D051379:Mice; D009469:Neuromuscular Junction / Q000187:drug effects / Q000502:physiology; D009638:Norepinephrine / Q000494:pharmacology; D010293:Pargyline / Q000494:pharmacology; D010649:Phenylalanine / Q000494:pharmacology; D010791:Phrenic Nerve; D051381:Rats; D012701:Serotonin / Q000494:pharmacology*; D014118:Toxins, Biological / Q000633:toxicity*
D000992:Antitoxins; D014118:Toxins, Biological; D012701:Serotonin; D010649:Phenylalanine; D002713:Chlorine; D006897:Hydroxyindoleacetic Acid; D010293:Pargyline; D006916:5-Hydroxytryptophan; D000109:Acetylcholine; D009638:Norepinephrine